Dose was defined as the highest dose reached within 12 months after semaglutide initiation
& Hoa, N
The American College of Obstetricians and Gynecologists, Breastfeeding Your Baby: Frequently Asked Questions, July 2023 The American College of Obstetricians and Gynecologists, Exercise After Pregnancy, October 2024 The American College of Obstetricians and Gynecologists, Weight Gain During Pregnancy, June 2013 Cleveland Clinic, GLP-1 Agonists, July 2023 Cleveland Clinic, Progestin, March 2023 Current Obesity Reports, Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over, June 2017 Diabetes Care (American Diabetes Association), GLP-1 Receptor Agonists and the Risk of Thyroid Cancer, November 2022 Frontiers in Endocrinology, Effects of GLP-1 Agonists and SGLT2 Inhibitors During Pregnancy and Lactation on Offspring Outcomes: A Systematic Review of the Evidence, October 2023 UCLA Health, Semaglutide for Weight Loss - What You Need to Know US Food and Drug Administration, FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss UT Southwestern Medical Center, 4 Factors That Can Decrease Breast Milk Supplyand How to Replenish It, May 2022 Real-parent perspectives: Kelley D., mom of two in Indiana Learn how we ensure the accuracy of our content through our editorial and medical review process
Frey II, a pioneer in intranasal central nervous system (CNS) delivery and adjunct professor at the University of Minnesota, explained it perfectly: We proved you could noninvasively deliver stem cells to the brain from the nose
Oral formulations may be particularly appropriate for patients with documented needle anxiety or injection-related psychological barriers that would prevent injectable therapy initiation or continuation, individuals whose travel schedules, living situations, or daily routines make weekly injection protocols impractical, those seeking maximum medication discretion where tablet administration offers advantages, patients preferring oral medication based on personal autonomy and comfort considerations, and individuals willing to commit to strict daily dosing protocols required for adequate oral absorption
This paper reviews the physiological, pharmacologic, and clinical foundations linking GLP-1 RA therapy to reproductive outcomes
